194 related articles for article (PubMed ID: 37020927)
1. Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors.
Sun TY; Nguyen B; Chen SB; Natkunam Y; Padda S; van de Rijn M; West R; Neal JW; Wakelee H; Riess JW
JTO Clin Res Rep; 2023 Apr; 4(4):100498. PubMed ID: 37020927
[TBL] [Abstract][Full Text] [Related]
2. Diffuse high intensity PD-L1 staining in thymic epithelial tumors.
Padda SK; Riess JW; Schwartz EJ; Tian L; Kohrt HE; Neal JW; West RB; Wakelee HA
J Thorac Oncol; 2015 Mar; 10(3):500-8. PubMed ID: 25402569
[TBL] [Abstract][Full Text] [Related]
3. Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses.
Ishihara S; Okada S; Ogi H; Kodama Y; Shimomura M; Tsunezuka H; Itoh K; Marx A; Inoue M
Lung Cancer; 2020 Jul; 145():40-47. PubMed ID: 32402921
[TBL] [Abstract][Full Text] [Related]
4. Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
Arbour KC; Naidoo J; Steele KE; Ni A; Moreira AL; Rekhtman N; Robbins PB; Karakunnel J; Rimner A; Huang J; Riely GJ; Hellmann MD
PLoS One; 2017; 12(8):e0182665. PubMed ID: 28771603
[TBL] [Abstract][Full Text] [Related]
5. Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor.
Jing X; Zhu H; Li Y; Jia W; Zhai X; Li J; Yu J
Immunotherapy; 2022 Oct; 14(14):1097-1107. PubMed ID: 36093721
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors.
Song JS; Kim D; Kwon JH; Kim HR; Choi CM; Jang SJ
Front Oncol; 2019; 9():1055. PubMed ID: 31681591
[No Abstract] [Full Text] [Related]
7. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
Front Oncol; 2021; 11():647512. PubMed ID: 34568003
[TBL] [Abstract][Full Text] [Related]
8. High levels of expression of Trop-2 in thymic epithelial tumors.
Yeung V; Zaemes J; Yeh J; Giancarlo C; Ahn J; Reuss JE; Kallakury BV; Liu SV; Duttargi A; Khan G; Kim C
Lung Cancer; 2023 Oct; 184():107324. PubMed ID: 37573703
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review.
Song X; Fan J; Zhu L; Wang Z; He Y; Zhou C
J Thorac Dis; 2021 Aug; 13(8):5093-5103. PubMed ID: 34527346
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor.
Yuan X; Huang L; Luo W; Zhao Y; Nashan B; Yu F; Liu Y
Front Oncol; 2021; 11():708735. PubMed ID: 34778027
[TBL] [Abstract][Full Text] [Related]
11. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors.
Xu S; Li X; Zhang H; Zu L; Yang L; Shi T; Zhu S; Lei X; Song Z; Chen J
Front Oncol; 2021; 11():667148. PubMed ID: 34307137
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma.
Katsuya Y; Fujita Y; Horinouchi H; Ohe Y; Watanabe S; Tsuta K
Lung Cancer; 2015 May; 88(2):154-9. PubMed ID: 25799277
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression and Tumor-Infiltrating Lymphocytes in Thymic Epithelial Neoplasms.
Higuchi R; Goto T; Hirotsu Y; Nakagomi T; Yokoyama Y; Otake S; Amemiya K; Oyama T; Omata M
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683962
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors.
Meurgey A; Girard N; Merveilleux du Vignaux C; Maury JM; Tronc F; Thivolet-Bejui F; Chalabreysse L
J Thorac Oncol; 2017 Oct; 12(10):1571-1581. PubMed ID: 28694035
[TBL] [Abstract][Full Text] [Related]
16. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets.
Alwahsh M; Knitsch R; Marchan R; Lambert J; Hoerner C; Zhang X; Schalke B; Lee DH; Bulut E; Graeter T; Ott G; Kurz KS; Preissler G; Schölch S; Farhat J; Yao Z; Sticht C; Ströbel P; Hergenröder R; Marx A; Belharazem D
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326714
[TBL] [Abstract][Full Text] [Related]
18. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
Shimada M; Taniguchi H; Yamaguchi H; Gyotoku H; Sasaki D; Kaku N; Senju C; Senju H; Imamura E; Takemoto S; Yamamoto K; Sakamoto N; Obase Y; Tsuchiya T; Fukuda M; Soda H; Ashizawa K; Fukuoka J; Nagayasu T; Yanagihara K; Mukae H
Transl Lung Cancer Res; 2023 Apr; 12(4):707-718. PubMed ID: 37197618
[TBL] [Abstract][Full Text] [Related]
19. Trends in Incidence and Survival of Patients With Thymic Epithelial Tumor in a High-Incidence Asian Country: Analysis of the Korean Central Cancer Registry 1999 to 2017.
Shin DW; Cho JH; Ha J; Jung KW
J Thorac Oncol; 2022 Jun; 17(6):827-837. PubMed ID: 35158083
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword.
Ballman M; Zhao C; McAdams MJ; Rajan A
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
